EMED / Electromedical Technologies, Inc. - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

OMB APPROVAL

OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB Number: Expires: 3235-0167 August 31, 2027 Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-56192 ELECTR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q For Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Trans

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q For Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Perio

Amended Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a).

Exhibit 31.1/A. Certification by Chief Executive Officer I, Matthew Wolfson, certify that: 1. I have reviewed the Annual Report on Form 10-K, as amended by this Form 10-K/A, of Electromedical Technologies, Inc. for the year ended December 31, 2023; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the s

Amended Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a).

Exhibit 31.2/A. Certification by Chief Financial Officer I, Matthew Wolfson, certify that: 1. I have reviewed the Annual Report on Form 10-K, as amended by this Form 10-K/A, of Electromedical Technologies, Inc. for the year ended December 31, 2023; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the s

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A

-12-31FY2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 000-56192

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000

Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on August 8, 2024, increasing the authorized common shares to 5 billion, one million and one shares.

Exhibit 3.1 STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION The corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows: 1. The name of the corporation is . 3. That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware. By:

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2024   ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation

Certificate of Amendment

Exhibit 3.1 STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION The corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows: 1. The name of the corporation is . 2. The Certificate of Incorporation of the corporation is hereby amended by changing the Article thereof numbered so that, as amended, said Article s

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2024   ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 00

Letter from dbbmckennon dated May 21, 2024, to the Securities and Exchange Commission.

Exhibit 16.1 May 21, 2024 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Dear Commissioners: We have read the statements made by Electromedical Technologies, Inc. (the “Company”), which we understand will be filed with the Securities and Exchange Commission. Pursuant to Item 4.01 of Form 8-K filed by the Company and dated May 21, 2024, we are in agreement with the stateme

Changes in Registrant's Certifying Accountant

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2024 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or org

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q For Period Ended: March 31, 2024 ¨ Transition Report on Form 10-K ¨ Transitio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q For Period Ended: March 31, 2024 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form N-SAR For the Transition Period En

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 000-561

April 3, 2024 Mutual Settlement and Release Agreement, Blue Lake Partners, LLC

Exhibit 10.15 SETTLEMENT AND MUTUAL RELEASE AGREEMENT THIS SETTLEMENT AND MUTUAL RELEASE AGREEMENT (this “Agreement”)dated as of April 3, 2024 (the “Effective Date”), is made by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation (the “Company”) and Blue Lake Partners, LLC, a Delaware limited liability company (the “Investor”) (the Company and the Investor are each also referred

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form 11-K ¨ Form 20-F ¨ Form 10-Q For Period Ended: December 31, 2023 ¨ Transition Report on Form 10-K ¨ Transi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form 11-K ¨ Form 20-F ¨ Form 10-Q For Period Ended: December 31, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form N-SAR For the Transition Period

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2024 ELECTROMEDICAL TECHNOLOGIES, INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2024 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or o

March 25, 2024 Mutual Settlement and Release Agreement, Mast Hill Fund LP

Exhibit 20.1 SETTLEMENT AND MUTUAL RELEASE AGREEMENT THIS SETTLEMENT AND MUTUAL RELEASE AGREEMENT (this “Agreement”) dated as of March 25, 2024 (the “Effective Date”), is made by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation (the “Company”) and Mast Hill Fund, L.P., a Delaware limited liability partnership (the “Investor”) (the Company and the Investor are each also referre

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Numbe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q For Period Ended: September 30, 2023 ¨ Transition Report on Form 10-K ¨ Trans

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q For Period Ended: September 30, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form N-SAR For the Transition Perio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q For Period Ended: June 30, 2023 ¨ Transition Report on Form 10-K ¨ Transition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q For Period Ended: June 30, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form N-SAR For the Transition Period End

Letter of Resignation

Exhibit 17 July 1, 2023 RE: Resignation from Electromedical Technologies, Inc. To the Board of Directors: Please accept this letter as formal notice as my resignation as a director of Electromedical Technologies, Inc. effective July 1, 2023. I have reviewed the draft disclosures that the Company intends to make on Form 8-K pertainingto my resignation as it relates to Item 502 and I agree with them

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2023 ELECTROMEDICAL TECHNOLOGIES, INC.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2023 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or org

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 00

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2023 ELECTROMEDICAL TECHNOLOGIES, INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2023 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or o

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023

Exhibit 10.7 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023

Exhibit 10.4 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023

Exhibit 10.9 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 3, 2022, by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, with headquarters located at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260 (the “Company”), and Blue Lake Partners, LLC, a Delaware limited liability company, with its address at 3411 Silverside

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023

Exhibit 10.13 SETTLEMENT AGREEMENT AND RELEASE This Confidential Settlement Agreement and Release (this “Agreement”) is entered into as of April 26, 2022, by and between “JR-HD Enterprises III, LLC” (“JR-HD”), its assigns or designees (“designees”) and “Electromedical Technologies, Inc.” (“EMED”). Collectively, JR-HD, its designees and EMED shall be referred to as the “Parties”. BACKGROUND WHEREAS

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023

Exhibit 10.12 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE R

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023

Exhibit 10.11 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE R

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 000-561

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023

Exhibit 10.10 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023

Exhibit 10.5 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023.

Exhibit 10.8 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE

Incorporated by reference from the Company’s Form 10-K filed March 31, 2023.

Exhibit 10.6 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 8, 2022, by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, with headquarters located at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260 (the “Company”), and Mast Hill Fund, L.P., a Delaware limited partnership, with its address at 48 Parker Road, Welle

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2023 ELECTROMEDICAL TECHNOLOGIES, INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2023 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or o

Purchase/Sale Agreement

Exhibit 10(i) AL MW MW MW AL MW MW AL MW AL AL MW MW AL MW MW MW AL MW AL MW MW AL MW MW AL AL MW MW MW MW MW AL MW AL AL MW MW MW MW Aaron Lebovitz (Feb 10, 2023 04:48 MST) AL Feb 10, 2023 CEO Matthew Wolfson (Feb 10, 2023 11:32 MST) Matthew Wolfson MW MW Feb 10, 2023 ceo@electromedtech.

Commercial Lease

Exhibit 10(ii) INITIALS INITIALS © 2017 AIR CRE. All Rights Reserved. Last Edited: 3/13/2023 10:42 AM STNAZ-16.00, Revised 10-22-2020 Page 1 of 16 ARIZONA STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE - NET (DO NOT USE THIS FORM FOR MULTI-TENANT BUILDINGS) 1. Basic Provisions ("Basic Provisions"). 1.1 Parties. This Lease ("Lease"), dated for reference purposes only , is made by and between Ca

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2023 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 ELECTROMEDICAL TECHNOLOGIES,

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation o

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2022 ELECTROMEDICAL TECHNOLOGIES,

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2022 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A

Table of Contents ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

October 6, 2022, First Amendment to Settlement Agreement and Release with JR-HD Enterprises III, LLC

Exhibit 10.63 ? First Amendment to Settlement Agreement ? This First Amendment to Settlement Agreement (?Amendment?) is entered into and effective October 6, 2022, by and between Electromedical Technologies, Inc., a Delaware corporation (?EMED?), and JR-HD Enterprises III, LLC (?JR-HD?). Both EMED and JR-HD may be collectively referred to as the ?Parties.? ? Recitals ? WHEREAS, on June 21, 2022, t

October 6, 2022, First Amendment to Settlement Agreement and Release with JR-HD Enterprises III, LLC

? Exhibit 10.63 ? First Amendment to Settlement Agreement ? This First Amendment to Settlement Agreement (?Amendment?) is entered into and effective October 6, 2022, by and between Electromedical Technologies, Inc., a Delaware corporation (?EMED?), and JR-HD Enterprises III, LLC (?JR-HD?). Both EMED and JR-HD may be collectively referred to as the ?Parties.? ? Recitals ? WHEREAS, on June 21, 2022,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Numbe

Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Unregistered Sales of Equity Securities

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2022 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation

December 3, 2020 Convertible Promissory Note with JR-HD Enterprises, III, LLC.

? Exhibit 10.55 ? THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS

June 21, 2022 Settlement Agreement and Release with JR-HD Enterprises III, LLC

? Exhibit 10.62 SETTLEMENT AGREEMENT AND RELEASE This Confidential Settlement Agreement and Release (this ?Agreement?) is entered into as of June 21, 2022 (?Effective Date?), by and between ?JR-HD Enterprises III, LLC? (?JR-HD?), its assigns or designees (?designees?) and ?Electromedical Technologies, Inc.? (?EMED?). Collectively, JR-HD, its designees and EMED shall be referred to as the "Parties"

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

July 21, 2020 Convertible Promissory Note with JRD-HD Enterprises III, LLC.

Exhibit 10.38 ?? THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY?NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS,

August 4, 2020 8% Convertible Note with JRD-HD Enterprises III, LLC.

? Exhibit 10.41 ? THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS

November 3, 2020 Convertible Note with JR-HD Enterprises, III, LLC.

Exhibit 10.51 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN

September 3, 2020 Convertible Promissory Note JR-HD Enterprises, III, LLC.

? Exhibit 10.44 ?? THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY?NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLES

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 6, 2022 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or org

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2022 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or org

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

First Amendment to Forbearance Agreement with JR-HD Enterprises III, LLC dated March 25, 2022

? Exhibit 10.62 ? First Amendment to the Forbearance Agreement Entered Into By and Between JR-HD Enterprises III, LLC and Electromedical Technologies, Inc. ? This First Amendment to Forbearance Agreement (this ?Agreement?) is entered into as of March 25, 2022, by and among JR-HD Enterprises III, LLC, a Delaware limited liability company (?JRD?) and Electromedical Technologies, Inc., a Delaware cor

February 11, 2022 Promissory Note, Mast Hill Fund, LP.

? Exhibit 10.24 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT F

February 11, 2022 Second Warrant, Mast Hill Fund, LP

Exhibit 10.27 ? NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 000-561

March 3, 2022 Second Warrant, Blue Lake Partners, LLP

EX-10.31 10 elcq-20211231xex10d31.htm EX-10.31 Exhibit 10.31 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OF

September 3, 2021 Forbearance Agreement, JRD-HD Enterprises, III, LLC.

Exhibit 10.17 ? Forbearance Agreement ? This Forbearance Agreement (this ?Agreement?) is entered into as of September 3, 2021 by and among JR-HD Enterprises III, LLC, a Delaware limited liability company (?JRD?) and Electromedical Technologies, Inc., a Delaware corporation (?EMED?). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Note (defin

March 25, 2022 First Amendment to Forbearance Agreement; JRD HD Enterprises

? Exhibit 10.32 ? First Amendment to the Forbearance Agreement Entered Into By and Between JR-HD Enterprises III, LLC and Electromedical Technologies, Inc. This First Amendment to Forbearance Agreement (this ?Agreement?) is entered into as of March 25, 2022, by and among JR-HD Enterprises III, LLC, a Delaware limited liability company (?JRD?) and Electromedical Technologies, Inc., a Delaware corpo

February 11, 2022 Securities Purchase Agreement, Mast Hill Fund, LP

EX-10.26 5 elcq-20211231xex10d26.htm EX-10.26 Exhibit 10.26 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 11, 2022, by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, with headquarters located at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260 (the “Company”), and Mast Hill Fund, L.P., a Delaware limited partne

March 3, 2022 Stock Purchase Agreement, Blue Lake Partners, LLP

? Exhibit 10.28 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of March 3, 2022, by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, with headquarters located at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260 (the ?Company?), and Blue Lake Partners, LLC, a Delaware limited liability company, with its address at 3411 Silvers

February 11, 2022 Warrant Agreement, Mast Hill Fund, LP

Exhibit10.25 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE

March 3, 2022 Promissory Note, Blue Lake Partners, LLP

EX-10.29 8 elcq-20211231xex10d29.htm EX-10.29 Exhibit 10.29 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE

March 3, 2022 Warrant Agreement, Blue Lake Partners, LLP

Exhibit 10.30 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE R

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2022 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or o

Certificate of Amendment

Exhibit 4(i) State of Delaware Secretary of State Division of Corporations Delivered 02:38 PM 03/14/2022 FILED 02:38 PM 03/14/2022 SR 2022099199S - FlleNumber 6521026STATE OF DELAWARE CERTIFICATE OF AMENDMENTOF CERTIFICATE OF INCORPORATIONThe corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify: FIRST: That at a meeting of the Board of Directors of ELECTROMEDICAL TECHNOLOGIES, INC.

As Filed With the Securities and Exchange Commission on March 2, 2022

As Filed With the Securities and Exchange Commission on March 2, 2022 Registration No.

Filing Fees table.*

EX-FILING FEES Calculation of Filing Fee Tables S-8 (Form Type) ELECTROMEDICAL TECHNOLOGIES, INC.

16561 N. 92nd St · Suite D101 · Scottsdale, AZ 85260 · Voice: (888)-880-7888 · Fax: 480-452-1518

January 18, 2022 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F.

September 3, 2021 Forbearance Agreement, JRD-HD Enterprises, III, LLC.

Exhibit 10.20 Forbearance Agreement This Forbearance Agreement (this ?Agreement?) is entered into as of September 3, 2021 by and among JR-HD Enterprises III, LLC, a Delaware limited liability company (?JRD?) and Electromedical Technologies, Inc., a Delaware corporation (?EMED?). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Note (defined b

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1/A-2 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter)

As filed with the U.S. Securities and Exchange Commission January 13, 2022 Registration No. 333-261802 UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1/A-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 5047 (Primary Standard Industrial

December 1, 2021, Note Settlement Agreement, Lock Up Leak Out Agreement, Blue Ridge Enterprises, LLC, Dianna Kaplan.

EX-10.30 4 tm222154d2ex10-30.htm EXHIBIT 10.30 Exhibit 10.30 Settlement Agreement & Release This Settlement Agreement & Release ("Agreement"), dated this 29th day of November, 2021, is by and between: · Electromedical Technologies, Inc. a Delaware corporation having a principal place of business at 16561 N. 92nd Street, Ste. 101, Scottsdale, AZ 85260 ("EMED"); · Blue Ridge Enterprises, LLC, a Cali

September 3, 2021 Forbearance Agreement, JRD-HD Enterprises, III, LLC.

Exhibit 10.20 Forbearance Agreement This Forbearance Agreement (this ?Agreement?) is entered into as of September 3, 2021 by and among JR-HD Enterprises III, LLC, a Delaware limited liability company (?JRD?) and Electromedical Technologies, Inc., a Delaware corporation (?EMED?). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Note (defined b

December 1, 2021, Note Settlement Agreement, Lock Up Leak Out Agreement, Blue Ridge Enterprises, LLC, Dianna Kaplan.

EX-10.30 4 tm222154d1ex10-30.htm EXHIBIT 10.30 Exhibit 10.30 Settlement Agreement & Release This Settlement Agreement & Release ("Agreement"), dated this 29th day of November, 2021, is by and between: · Electromedical Technologies, Inc. a Delaware corporation having a principal place of business at 16561 N. 92nd Street, Ste. 101, Scottsdale, AZ 85260 ("EMED"); · Blue Ridge Enterprises, LLC, a Cali

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1/A REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter)

As filed with the U.S. Securities and Exchange Commission January 6, 2022 Registration No. 333-261802 UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 5047 (Primary Standard Industrial Cla

December 28, 2021

CORRESP 1 filename1.htm December 28, 2021 Ms. Laura Crotty Mr. Dillon Hagius Securities and Exchange Commission Division of Corporation Finance 100 F Street NW Washington, DC 20549 Re: Electromedical Technologies, Inc. Registration Statement on Form S-1 Filed December 21, 2021 File No. 333-261802 Your Correspondence dated December 28, 2021 Dear Ms. Crotty and Mr. Hagius: The following responses ar

September 3, 2021 Forbearance Agreement, JRD-HD Enterprises, III, LLC.

Exhibit 10.17 Forbearance Agreement This Forbearance Agreement (this ?Agreement?) is entered into as of September 3, 2021 by and among JR-HD Enterprises III, LLC, a Delaware limited liability company (?JRD?) and Electromedical Technologies, Inc., a Delaware corporation (?EMED?). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Note (defined b

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter)

As filed with the U.S. Securities and Exchange Commission December 21, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 5047 (Primary Standard Industrial Classific

December 21, 2021

December 21, 2021 By EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7010 Re: Electromedical Technologies, Inc. Registration Statement on Form S-1 (File No. 333-261802) Ladies and Gentlemen: Reference is made to the Registration Statement on Form S-1 (File No. 333-261802) filed by Electromedical Technologies, Inc. on December 21, 2021 (the ?Registration Statement

December 1, 2021, Note Settlement Agreement, Lock Up Leak Out Agreement, Blue Ridge Enterprises, LLC, Dianna Kaplan.

Exhibit 10.23 SETTLEMENT AGREEMENT & RELEASE This Settlement Agreement & Release ("Agreement"), dated this 1st day of December, 2021, is by and between: ? Electromedical Technologies, Inc. a Delaware corporation having a principal place of business at 16561 N. 92nd Street, Ste. 101, Scottsdale, AZ 85260 ("EMED"); ? Blue Ridge Enterprises, LLC, a California limited liability company (?Blue Ridge?),

Incorporated by reference from the Company’s Form 10-Q filed November 15, 2021.

Exhibit 10.60 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 10, 2021 (the “Execution Date”), is entered into by and between Electromedical Technologies, Inc., a Delaware corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used her

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Numbe

Incorporated by reference from the Company’s Form 10-Q filed November 15, 2021.

EX-10.61 4 elcq-20210930xex10d61.htm EX-10.61 Exhibit 10.61 COMMON STOCK PURCHASE AGREEMENT This Common Stock Purchase Agreement is entered into effective as of this 10th day of November, 2021 (this “Agreement”), by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and WHITE LION CAPITAL LLC, a Nevada limited liability company (the “Investor”). WHEREAS, the par

Incorporated by reference from the Company’s Form 10-Q filed November 15, 2021.

Exhibit 10.59 ? PLACEMENT AGENCY AGREEMENT ? November 10, 2021 ? Univest Securities LLC Investment Banking 375 Park Avenue, 15th Fl. New York, New York 10152 ? Ladies and Gentlemen: ? Subject to the terms and conditions herein (this ?Agreement?) and the Transaction Documents (defined below), Electromedical Technologies, Inc., a Delaware company (the ?Company?), hereby agrees to sell, to Investors

Incorporated by reference from the Company’s Form 8-K filed October 21, 2021 .

Exhibit 10.6 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE

Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on October 14, 2021, increasing authorized common shares to 251 million shares.

Exhibit 4.(i)

Incorporated by reference from the Company’s Form 8-K filed October 21, 2021.

Exhibit 10.4 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of October 13, 2021, by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, with headquarters located at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260 (the ?Company?), and Talos Victory Fund, LLC, a Delaware limited liability company, with its address at 348 Cambridg

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2021 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other jurisdiction of incorporation or

Convertible Promissory Note

Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

Incorporated by Incorporated by reference from the Company's Form 8-K filed October 21, 2021.

EX-10.3 5 tm2130685d1ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFER

Incorporated by reference from the Company’s Form 8-K filed October 21, 2021.

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of October 13, 2021, by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, with headquarters located at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260 (the ?Company?), and Mast Hill Fund, L.P., a Delaware limited partnership, with its address at 48 Parker Road, Welle

Incorporated by reference from the Company’s Form 8-K filed October 21, 2021 .

Exhibit 10.5 THIS INSTRUMENT CONTAINS AN AFFIDAVIT OF CONFESSION OF JUDGMENT PROVISION WHICH CONSTITUTES A WAIVER OF IMPORTANT RIGHTS BORROWER MAY HAVE AND ALLOWS THE HOLDER TO OBTAIN A JUDGMENT AGAINST BORROWER WITHOUT ANY FURTHER NOTICE. NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTE

EMED / Electromedical Technologies Inc / Kaplan Dianna - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 ELECTROMEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $.00001 (Title of Class of Securities) 28540Q100 (CUSIP Number) November 9, 2020 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to w

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A

Table of Contents ? ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021. ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-56192 ELECTROMED

16561 N. 92nd St · Suite D101 · Scottsdale, AZ 85260 · Voice: (888)-880-7888 · Fax: 480-452-1518

CORRESP 1 filename1.htm May 4, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Electromedical Technologies, Inc. (the "Company") Registration Statement on Form S-1/A filed April 28, 2021 File No. 333-253589 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned

- FORM S-1/A

As filed with the U.S. Securities and Exchange Commission April 27, 2021 Registration No. 333-253589 UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 5047 (Primary Standard Industrial Clas

July 21, 2020 Securities Purchase Agreement with JRD-HD Enterprises III, LLC.

EX-10.39 3 tm214059d1ex10-39.htm EXHIBIT 10.39 Exhibit 10.39 NOTE PURCHASE AGREEMENT BY AND AMONG ELECTROMEDICAL TECHNOLOGIES, INC. AND JR-HD ENTERPRISES III, LLC DATED AS OF JULY 21, 2020 TABLE OF CONTENTS ARTICLE I. DEFINITIONS 1 SECTION 1.01 DEFINITIONS 1 SECTION 1.02 INTERPRETIVE PROVISIONS 3 ARTICLE II. PURCHASE AND SALE 3 SECTION 2.01 PURCHASE AND SALE. 3 SECTION 2.02 DELIVERABLES AT CLOSING

December 3, 2020 Securities Purchase Agreement with JR-HD Enterprises, III, LLC.

Exhibit 10.54 Note Purchase Agreement By And Among Electromedical Technologies, Inc. And Jr-hd Enterprises iii, Llc Dated As Of December 3, 2020 TABLE OF CONTENTS ARTICLE I. DEFINITIONS 1 Section 1.01 Definitions 1 Section 1.02 Interpretive Provisions 2 ARTICLE II. PURCHASE AND SALE 3 Section 2.01 Purchase and Sale 3 Section 2.02 Deliverables at Closing 3 Section 2.03 Closing 3 Section 2.04 Use of

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

EX-10.47 9 tm214059d1ex10-47.htm EXHIBIT 10.47 Exhibit 10.47   SECURITIES PURCHASE AGREEMENT   This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 8, 2020, by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, with its address at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260 (the “Company”), and REDSTART HOLDINGS CORP., a New York corporation, wi

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

EX-10.42 4 tm214059d1ex10-42.htm EXHIBIT 10.42   Exhibit 10.42   NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE

November 3, 2020 Securities Purchase Agreement with JR-HD Enterprises, III, LLC.

EX-10.50 12 tm214059d1ex10-50.htm EXHIBIT 10.50 Exhibit 10.50 NOte Purchase Agreement By And Among Electromedical Technologies, Inc. And JR-HD Enterprises III, LLC Dated as of November 3, 2020 TABLE OF CONTENTS ARTICLE I. DEFINITIONS 1 Section 1.01 Definitions 1 Section 1.02 Interpretive provisions 3 ARTICLE II. PURCHASE AND SALE 3 Section 2.01 Purchase and sale 3 section 2.02 Deliverables at clos

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

EX-10.43 5 tm214059d1ex10-43.htm EXHIBIT 10.43 Exhibit 10.43   SECURITIES PURCHASE AGREEMENT   This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 11, 2020, by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, with its address at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260 (the “Company”), and REDSTART HOLDINGS CORP., a New York corporation, with

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

EX-10.38 2 tm214059d1ex10-38.htm EXHIBIT 10.38   Exhibit 10.38   THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICA

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

Exhibit 20.1 Amendment and Adoption to Electromedical Technologies, Inc. 2017 Employee and Consultant Stock Ownership Plan [Effective February 16, 2021] Pursuant to Section 15(a) of the 2017 Employee and Consultant Stock Ownership Plan [?Plan?], the Company by resolution effective February 16, 2021, amends and adopts the following amendments to the Plan. 1. Purpose. The purpose of this Plan is to

December 14, 2020 Securities Purchase Agreement with GS Capital Partners, LLC.

EX-10.56 18 tm214059d1ex10-56.htm EXHIBIT 10.56 Exhibit 10.56 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 14, 2020, by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, with headquarters located at 16561 N. 92nd Street, Suite 101, Scottsdale, AZ 85260 (the “Company”), and GS CAPITAL PARTNERS, LLC a New York limited l

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

EX-10.51 13 tm214059d1ex10-51.htm EXHIBIT 10.51 Exhibit 10.51   THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICAB

September 8, 2020 10% Convertible Promissory Note with Redstart Holdings Corp.

EX-10.46 8 tm214059d1ex10-46.htm EXHIBIT 10.46 Exhibit 10.46 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

EX-10.45 7 tm214059d1ex10-45.htm EXHIBIT 10.45 Exhibit 10.45 Note Purchase Agreement By AND Among ELECTROMEDICAL TECHNOLOGIES, INC. AND JR-HD Enterprises III, LLC Dated AS OF September 3, 2020 TABLE OF CONTENTS ARTICLE I. DEFINITIONS 1 Section 1.01 Definitions 1 Section 1.02 Interpretive provisions 3 ARTICLE II. PURCHASE AND SALE 3 Section 2.01 Purchase and Sale 3 Section 2.02 Deliverables at Clos

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

Exhibit 10.44 ? THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY?NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS,?

December 3, 2020 Convertible Promissory Note with JR-HD Enterprises, III, LLC.

Exhibit 10.55 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN

Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 000-56192 ELECTROMEDICAL

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

Exhibit 10.57 THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT?) US $110,

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

EX-10.49 11 tm214059d1ex10-49.htm EXHIBIT 10.49 Exhibit 10.49   NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

Exhibit 10.52   NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

December 1, 2020 Securities Purchase Agreement with Jefferson Street Capital, LLC.

EX-10.53 15 tm214059d1ex10-53.htm EXHIBIT 10.53 Exhibit 10.53 SECURITIES PURCHASE AGREEMENT A.           This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 1, 2020, by and between ELECTROMEDICAL TECHNOLOGIES INC., a Delaware corporation with its address at 16561 N. 92nd Street, Suite 101, Scottsdale, Arizona 85260 (the “Company”), and JEFFERSON STREET CAPITAL LLC, a New Jer

Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

Exhibit 10.48 NEITHER THIS NOTE NOR THE SECURITIES THAT MAY BE ISSUED BY THE COMPANY UPON CONVERSION HEREOF (COLLECTIVELY, THE “SECURITIES”) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THE SECURITIES NOR ANY INTEREST OR PARTICIPATION THEREIN MAY BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIG

Consulting Agreement Redstone Communications, LLC, February 27, 2020

EX-10.23 31 tm2180171d1ex10-23.htm EXHIBIT 10.23 Exhibit 10.23

Stock Purchase Agreement Petar Gajic, March 25, 2019

EX-10.11 19 tm2180171d1ex10-11.htm EXHIBIT 10.11 EXHIBIT 10.11 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is dated as of this 25” day of March, 2019 by and between Matthew Wolfson (the ASeller”) and Petar Gajic (the “Buyer’). WHEREAS, the Buyer is an employee of Electromedical Technologies, Inc., a Delaware company (the “Company”); and WHEREAS, previously, the Seller had orally agreed

Registration Statement - FORM S-1

As filed with the U.S. Securities and Exchange Commission February 26, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 5047 (Primary Standard Industrial Classific

2017 Employee and Consultant Stock Ownership Plan

Exhibit 20.1

Convertible Promissory Note, Ben and Carol Howden, May 2018

Exhibit 10.28

KISS Agreement Blue Ridge Enterprises, LLC, July 6, 2018

EX-10.20 28 tm2180171d1ex10-20.htm EXHIBIT 10.20 Exhibit 10.20

Option Agreement Kishkovskiy, March 11, 2019

Exhibit 10.13 ELECTROMEDICAL TECHNOLOGIES, INC. AWARD AGREEMENT - 2017 EMPLOYEE AND CONSULTANT STOCK OWNERSHIP PLAN - OPTIONS Participant Name: Kostiantyn Kishkovskiy Participant ID: N/A Type of Option: Nonstatutory Stock Option Grant Date: March 11, 2019 Exercise Price: $0.71 Shares Granted: 100,000 Term and Vesting Date(s): Only if the participant is still a consultant or employee of Electromedi

Consulting Agreement, Brenda Andrews, July 1, 2019

EX-10.7 15 tm2180171d1ex10-7.htm EXHIBIT 10.7 Exhibit 10.7 Consulting Agreement This consulting agreement (the “Agreement”) is made and entered on this day 1“ day of July, 2019 (the “Effective Date”) by and between Brenda Andrews (hereinafter referred to as the “Consultant”) and Electromedical Technologies, Inc. (hereinafter referred to as the “Client”). 1. Services The Consultant will provide str

Consent Action for Iakovos Tsakalidis, October 25, 2019

EX-10.25 33 tm2180171d1ex10-25.htm EXHIBIT 10.25 Exhibit 10.25

Stock Purchase Agreement, Kelly Lauren Myers, March 25, 2019

EX-10.14 22 tm2180171d1ex10-14.htm EXHIBIT 10.14 Exhibit 10.14 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is dated as of this 25th day of March, 2019 by and between Matthew Wolfson (the “Seller’) and Kelly Lauren Myers (the “Buyer’). WHEREAS, the Buyer is an employee of Electromedical Technologies, Inc., a Delaware company (the “Company’”); and WHEREAS, Previously, the Seller has orall

Consent Action for Iakovos Tsakalidis Issuance, October 11, 2019

EX-10.12 20 tm2180171d1ex10-12.htm EXHIBIT 10.12 Exhibit 10.12 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”), hereby unanimously consent to the following actions taken on Company on October 11, 2019. RESOLVED: To issue Iakovos Ts

Consent Action PYP Enterprises July 1, 2019

EX-10.17 25 tm2180171d1ex10-17.htm EXHIBIT 10.17 Exhibit 10.17 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”), hereby unanimously consents to the following actions taken by the Company on October 11, 2019. RESOLVED: To confirm the

Consulting Agreement PYP Enterprises, July 1, 2018

EX-10.18 26 tm2180171d1ex10-18.htm EXHIBIT 10.18 Exhibit 10.18 Consulting Agreement This consulting agreement (the “Agreement”) is made and entered on this day 1st day of July, 2019 (the “Effective Date”) by and between PYP Enterprises (hereinafter referred to as the “Consultant”) and Electromedical Technologies, Inc. (hereinafter referred to as the “Client”). 1. Services The Consultant will provi

Rule 10b5-1 Sales Plan – Wolfson

EX-10.2 10 tm2180171d1ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 ELECTROMEDICAL TECHNOLOGIES, INC. Rule 10b5-1 Sales Plan (Stock Only) NOTE: This Sales Plan contains conditional limitations on the Seller’s ability to sell stock registered on Form S-1 and receive dollar values from the sales of stock. Sales Plan dated January 9, 2020 (together with all Exhibits hereto, this “Sales Plan”) between Matthew

Consulting Agreement, Robert L. Hymers III, February 11, 2019

EX-10.32 40 tm2180171d1ex10-32.htm EXHIBIT 10.32 Exhibit 10.32 Consulting Agreement This consulting agreement (the "Agreement") is made and entered on this day 11th day of February (the "Effective Date") by and between Robert L. Hymers III (hereinafter referred to as the "Consultant") and Electromedical Technologies, Inc. (hereinafter referred to as the "Client"). 1. Services The Consultant will p

Certificate of Incorporation -

EX-3.1(I) 2 tm2180171d1ex3-1i.htm EXHIBIT 3.1(I) Exhibit 3.1(i) State of Delaware Secretary of State Division of Corporations Delivered 09:10 PM 08/23/2017 FILED 09:10 PM 08/23/2017 SR 20175863573 - File Number 6521026 CERTIFICATE OF INCORPORATION OF ELECTROMEDICAL TECHNOLOGIES, INC. ARTICLE I The name of the corporation is ElectroMedical Technologies, Inc. (the “Corporation”). ARTICLE II The addr

E-Business International, Inc. Stock Purchase Agreement, November 29, 2018

EX-10.5 13 tm2180171d1ex10-5.htm EXHIBIT 10.5 Exhibit 10.5 STOCK ISSUANCE AGREEMENT This Stock Issuance Agreement (“Agreement”) is entered into as of the 29th day of November 2018 by and between Electromedical Technologies, Inc., a Delaware corporation (the “Company”), and E-Business International, Inc., an Oregon company, (“EBI”). WHEREAS, on or about 2005, EBI began rendering services to the Com

Convertible Promissory Note dated June 4, 2020 with Vista Capital Investments, LLC

EX-10.36 44 tm2180171d1ex10-36.htm EXHIBIT 10.36 Exhibit 10.36 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, AC

Notice of Conversion - Howden, October 24, 2019

Exhibit 10.29

Sales Agreement Edgar Villanueva, October 25, 2017

EX-10.24 32 tm2180171d1ex10-24.htm EXHIBIT 10.24 Exhibit 10.24

Consulting Agreement Robert L. Hymers III, February 11, 2020

EX-10.22 30 tm2180171d1ex10-22.htm EXHIBIT 10.22 Exhibit 10.22 1 2 3 4 5 Page 1 of 1

Options Agreement Alexander Pedenko June 20, 2019

EX-10.16 24 tm2180171d1ex10-16.htm EXHIBIT 10.16 Exhibit 10.16 ELECTROMEDICAL TECHNOLOGIES, INC. AWARD AGREEMENT - 2017 EMPLOYEE AND CONSULTANT STOCK OWNERSHIP PLAN - OPTIONS Participant Name: Alexander Pedenko Participant ID: N/A Type of Option: Nonstatutory Stock Option Grant Date: 6/20/2019 Exercise Price: $0.71 Shares Granted: 100,000 Term and Vesting Date(s): Only if the participant is still

Consent Action Nikolai Ogorodnikov Issuance October 11, 2019

EX-10.15 23 tm2180171d1ex10-15.htm EXHIBIT 10.15 Exhibit 10.15 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”), hereby unanimously consent to the following actions taken on Company on October 11, 2019. RESOLVED: To issue Nikolai Og

Employment Contract; Matthew Wolfson Chief Executive Officer, as amended.

Exhibit 10.1 PRESIDENT - CHIEF EXECUTIVE OFFICER EMPLOYMENT CONTRACT This agreement is made and effective as of October 1st 2019 by and between Electromedical Technologies, Inc., a Delaware corporation (the “Employer”) and Matthew Wolfson (“Executive”) and supersedes any prior employment-related agreement or agreements between the Employer and Executive. Unless the context otherwise requires, all

Stock Purchase Agreement dated June 15, 2020 with Pro Active Partners

EX-10.34 42 tm2180171d1ex10-34.htm EXHIBIT 10.34 Exhibit 10.34 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (“Agreement”) is made and entered into this 12th day of June, 2020, by and between ElectroMedical Technologies, Inc., a Delaware corporation, with a business address of 16561 N 92nd Street Ste. 101, Scottsdale AZ 85260 (“Seller”), and ProActive Capital Partners, LP, a Delaware limi

Amended Articles of Incorporations January 9, 2020

Exhibit 3.1(i)(a)

Certificate of Amendment [Increase of Authorized Common Stock to 50 million Shares]

Exhibit 3.1(i)(b)

Corporate Bylaws

EX-3.1(II)(E) 7 tm2180171d1ex3-1iie.htm EXHIBIT 3.1(II)(E) Exhibit 3.1(ii)(e) BYLAWS OF ELECTROMEDICAL TECHNOLOGIES, INC. ARTICLE I CORPORATE OFFICES 1.1 Offices In addition to the corporation’s registered office set forth in the certificate of incorporation, the Board of Directors may at any time establish other offices at any place or places where the corporation is qualified to do business. ART

Consulting Agreement, Blue Ridge Enterprises, July 9, 2019

EX-10.8 16 tm2180171d1ex10-8.htm EXHIBIT 10.8 Exhibit 10.8

E-Business International, Inc. Stock Purchase Agreement Product Development, November 29, 2018

EX-10.6 14 tm2180171d1ex10-6.htm EXHIBIT 10.6 Exhibit 10.6 DEVELOPMENT STOCK ISSUANCE AGREEMENT This Development Stock Issuance Agreement (“Agreement”) is entered into as of the 29th day of November, 2018 by and between Electromedical Technologies, Inc., a Delaware corporation (the “Company”), and E-Business International, Inc., a Oregon company, (“EBI”). NOW THEREFORE, in consideration of the mut

Certificate of Amendment Converting to C Corporation from limited liability company

EX-3.1(I)(D) 6 tm2180171d1ex3-1id.htm EXHIBIT 3.1(I)(D) Exhibit 3.1(i)(d)

Consultant Agreement and BOD Resolution, October 21, 2019

EX-10.9 17 tm2180171d1ex10-9.htm EXHIBIT 10.9 Exhibit 10.9 SPECIAL MEETING & RESOLUTION OF THE DIRECTORS ELECTROMEDICAL TECHNOLOGIES, INC. A Delaware Corporation The undersigned, being all the Directors of Electromedical Technologies, Inc., a Delaware Corporation (the “Company”), hereby adopt the following recitals and resolutions after the holding of a Special Meeting of the Board of Directors pu

Agility Warrant Agreement, May 1, 2020

Exhibit 10.4 THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. ELECTROMEDICAL

Amended Consulting Agreement, Robert L. Hymers III, June 28, 2019

EX-10.33 41 tm2180171d1ex10-33.htm EXHIBIT 10.33 Exhibit 10.33

Taubman Subscription Agreement, October 31, 2018

Exhibit 10.30

Stock Purchase Agreement dated June 4, 2020 with Vista Capital Investments, LLC

Exhibit 10.35 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June 4, 2020, is entered into by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, (the “Company”), and VISTA CAPITAL INVESTMENTS, LLC (the “Buyer”). A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securitie

Securities Purchase Agreement Yorkville

Exhibit 10.37 EXHIBIT C SECURITIES PURCHASE AGREEMENT THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRA

Consent Action for Gene Taubman, October 31, 2018

EX-10.31 39 tm2180171d1ex10-31.htm EXHIBIT 10.31 Exhibit 10.31

Consent Action for Nikolai Ogorodnikov, October 25, 2019

EX-10.26 34 tm2180171d1ex10-26.htm EXHIBIT 10.26 Exhibit 10.26

Certificate of Amendment [Designating Series A Preferred]

EX-3.1(I)(C) 5 tm2180171d1ex3-1ic.htm EXHIBIT 3.1(I)(C) Exhibit 3.1(i)(c)

Amendment to KISS Agreement, March 22, 2019

EX-10.27 35 tm2180171d1ex10-27.htm EXHIBIT 10.27 Exhibit 10.27

Convertible Promissory Note Luis Lu December 11, 2019

Exhibit 10.21 CONVERTIBLE PROMISSORY NOTE NEITHER THIS NOTE, NOR THE COMMON STOCK THIS NOTE IS CONVERTIBLE INTO, HAS, AS OF THE ISSUANCE DATE, BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE COMPANY OF AN OPINION OF COUN

Stock Purchase Agreement Nicholas Rosin, March 25, 2019

Exhibit 10.19 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is dated as of this 25th day of March, 2019 by and between Matthew Wolfson (the ?Seller?) and Nicholas Rosin (the ?Buyer?). WHEREAS, the Buyer is an employee of Electromedical Technologies, Inc., a Delaware company (the ?Company??); and WHEREAS, Previously, the Seller has orally agreed to sell 25,000 shares of his shares of the C

Agility Warrant Agreement, December 1, 2018

EX-10.3 11 tm2180171d1ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUC

Stock Purchase Agreement Stephanie Campbell, March 25, 2019

Exhibit 10.10 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is dated as of this 25th day of March, 2019 by and between Matthew Wolfson (the “Seller’) and Stephanie Kay Campbell (the “Buyer’). WHEREAS, the Buyer is an employee of Electromedical Technologies, Inc., a Delaware company (the “Company”); and WHEREAS, Previously, the Seller has orally agreed to sell 50,000 shares of his shares o

- FORM S-8

As Filed With the Securities and Exchange Commission on February 16, 2021 Registration No.

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement

8-K 1 tm216566d18k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2021 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware Commission File Number 82-2619815 (State or other

Incorporated by reference from the Company’s Form 8-K filed February 12, 2021.

Exhibit 10(iv) EXECUTION VERSION REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of February 8, 2021, by and among ELECTROMEDICAL TECHNOLOGIES, INC.

Incorporated by reference from the Company’s Form 8-K filed February 12, 2021.

EX-10.(II) 3 tm216566d1ex10-ii.htm EXHIBIT 10(II) Exhibit 10(ii) EXECUTION VERSION NEITHER THIS DEBENTURE NOR THE SECURITIES INTO WHICH THIS DEBENTURE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (

Incorporated by reference from the Company’s Form 8-K filed February 12, 2021.

Exhibit 10(iii) EXECUTION VERSION WARRANT THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

February 8, 2021 Securities Purchase Agreement, Warrant Agreement, Convertible Debenture and Registration Rights Agreement with YA II PN, Ltd.

Exhibit 10(i) EXEUTION VERSION SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this ?Agreement?), dated as of February 8, 2021, by and among ELECTROMEDICAL TECHNOLOGIES, INC.

Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on December 3, 2020, increasing authorized common stock to 125 million shares.

Exhibit 3(i)

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits - FORM 8-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2020 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or other jurisdiction of incorporation or organization) Commission File Num

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020. ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-56192 ELECTR

Convertible Promissory Note, Redstart Holdings Corp., October 22, 2020.

Exhibit 10(vi) NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Convertible Promissory Note, JR-HD Enterprises, III, LLC, November 3, 2020

Exhibit 10(vii) Note Purchase Agreement By and Among Electromedical Technologies, Inc.

Convertible Promissory Note, JSJ Investments, Inc., September 28, 2020, as completed October 1, 2020.

Exhibit 10(v) DocuSign Envelope ID: 39B6801E-C97B-406A-9620-579BB3F3D9FA NEITHER THIS NOTE NOR THE SECURITIES THAT MAY BE ISSUED BY THE COMPANY UPON CONVERSION HEREOF (COLLECTIVELY, THE ?SECURITIES?) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?1933 ACT?), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION.

Settlement Agreement, Iakovos Tsakalidis, November 6, 2020

Exhibit 10(viii) Settlement Agreement & Release This Settlement Agreement & Release ("Agreement"), dated this 9th day of November, 2020 is by and between Electromedical Technologies, Inc.

Quarterly Report - FORM 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020. ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-56192 ELECTROME

Convertible Promissory Note, JRD Enterprises III, LLC, July 21, 2020

Exhibit 10(iii) THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS.

Convertible Promissory Note, JRD Enterprises III, LLC, August 4, 2020

Exhibit 10(iv) THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS.

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020. ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-56192 ELECTROMEDI

Note Purchase Agreement with JRD-HD Enterprises III, LLC.

Exhibit 10.38 Note Purchase Agreement By and Among Electromedical Technologies, Inc. And JR-HD Enterprises III, LLC Dated as of July [], 2020 TABLE OF CONTENTS Article I. DEFINITIONS 1 Section 1.01 Definitions. 1 Section 1.02 Interpretive Provisions. 2 Article II. PURCHASE AND SALE 3 Section 2.01 Purchase and Sale. 3 Section 2.02 Deliverables at Closing. 3 Section 2.03 Closing. 3 Section 2.04 Use

-

August 5, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F.

Incorporated by reference to the Company’s Form 8a-12g filed August 5, 2020.

Exhibit 10.40 NOTE PURCHASE AGREEMENT BY AND AMONG ELECTROMEDICAL TECHNOLOGIES, INC. AND JR-HD ENTERPRISES III, LLC DATED AS OF AUGUST 4, 2020 NOTE PURCHASE AGREEMENT This Note Purchase Agreement (together with all exhibits hereto, this “Agreement”) is entered into as of August 4, 2020 (the “Closing Date”), by and among Electromedical Technologies, Inc., a Delaware corporation (the “Company”) and

8% Convertible Note with JRD-HD Enterprises III, LLC.

Exhibit 10.39 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN

Incorporated by reference to the Company’s Form 8a-12g filed August 5, 2020.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ELECTROMEDICAL TECHNOLOGIES, INC.

Incorporated by reference to the Company’s Form 8a-12g filed August 5, 2020.

Exhibit 10.41 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN

-

July 24, 2020 Eric Atallan Lynn Dicker United States Securities & Exchange Commission Division of Corporation Finance 100 F Street, NE Washington , D.

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.23

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.13 ELECTROMEDICAL TECHNOLOGIES, INC. AWARD AGREEMENT - 2017 EMPLOYEE AND CONSULTANT STOCK OWNERSHIP PLAN - OPTIONS Participant Name: Kostiantyn Kishkovskiy Participant ID: N/A Type of Option: Nonstatutory Stock Option Grant Date: March 11, 2019 Exercise Price: $0.71 Shares Granted: 100,000 Term and Vesting Date(s): Only if the participant is still a consultant or employee of Electromedi

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.2 ELECTROMEDICAL TECHNOLOGIES, INC. Rule 10b5-1 Sales Plan (Stock Only) NOTE: This Sales Plan contains conditional limitations on the Seller’s ability to sell stock registered on Form S-1 and receive dollar values from the sales of stock. Sales Plan dated January 9, 2020 (together with all Exhibits hereto, this “Sales Plan”) between Matthew Wolfson (“Seller”), Glendale Securities (“Glen

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.14 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is dated as of this 25th day of March, 2019 by and between Matthew Wolfson (the “Seller’) and Kelly Lauren Myers (the “Buyer’). WHEREAS, the Buyer is an employee of Electromedical Technologies, Inc., a Delaware company (the “Company’”); and WHEREAS, Previously, the Seller has orally agreed to sell 18,750 shares of his shares of t

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.30 ACCREDITED SUBSCRIPTION AGREEMENT This Accredited Subscription Agreement ("Agreement”) is entered into as of the 31 day of October 2018 by and between Electromedical Technologies, Inc., a Delaware corporation (the "Company"), and the undersigned investor, Gene Taubman, (the "Investor"). If more than one person signs this Agreement as an investor, then all references to Investor in th

Convertible Promissory Note dated June 4, 2020 with Vista Capital Investments, LLC.

Exhibit 10.36 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURS

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

EXHIBIT 10.11 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is dated as of this 25" day of March, 2019 by and between Matthew Wolfson (the ASeller”) and Petar Gajic (the “Buyer’). WHEREAS, the Buyer is an employee of Electromedical Technologies, Inc., a Delaware company (the “Company”); and WHEREAS, previously, the Seller had orally agreed to sell 500,000 of his shares of the Company (the

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.21 CONVERTIBLE PROMISSORY NOTE NEITHER THIS NOTE, NOR THE COMMON STOCK THIS NOTE IS CONVERTIBLE INTO, HAS, AS OF THE ISSUANCE DATE, BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE COMPANY OF AN OPINION OF COUN

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.26 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the "Company"), hereby unanimously consent to the following actions taken on Company on October 25, 2019. RESOLVED: Due to a mathematical error on the part of the Company, to issue Nik

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.37 THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STA

Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on November 1, 2019 designating Series A Preferred Shares.

Exhibit 3.1(i)(c) ELECTROMEDICAL TECHNOLOGIES, INC.CERTIFICATE OF DESIGNATION OF SERIES A PREFERRED STOCK, SETTING FORTH THE POWERS, PREFERENCES, RIGHTS, QUALIFICATIONS, LIMITATIONS AND RESTRICTIONS OF SUCH SERIES OF PREFERRED STOCKAND BOARD RESOLUTION SO AUTHORIZINGPursuant to Section 151 of the Delaware General Corporation Law, Electromedical Technologies, Inc., a Delaware corporation (the “Corp

Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on July 9, 2020 increasing authorized common stock to 50 million shares.

Exhibit 3.1(i)(b) STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION The corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify: FIRST: That at a meeting of the Board of Directors of resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of said corporat

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 3.1(i) State of Delaware Secretary of State Division of Corporations Delivered 09:10 PM 08/23/2017 FILED 09:10 PM 08/23/2017 SR 20175863573 - File Number 6521026 CERTIFICATE OF INCORPORATION OF ELECTROMEDICAL TECHNOLOGIES, INC. ARTICLE I The name of the corporation is ElectroMedical Technologies, Inc. (the "Corporation"). ARTICLE II The address of the Corporation's registered office in the

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.9 SPECIAL MEETING & RESOLUTION OF THE DIRECTORS ELECTROMEDICAL TECHNOLOGIES, INC. A Delaware Corporation The undersigned, being all the Directors of Electromedical Technologies, Inc., a Delaware Corporation (the “Company”), hereby adopt the following recitals and resolutions after the holding of a Special Meeting of the Board of Directors pursuant to Section 3.7 of the Company’s By Laws

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.1 PRESIDENT - CHIEF EXECUTIVE OFFICER EMPLOYMENT CONTRACT This agreement is made and effective as of October 1st 2019 by and between Electromedical Technologies, Inc., a Delaware corporation (the “Employer”) and Matthew Wolfson (“Executive”) and supersedes any prior employment-related agreement or agreements between the Employer and Executive. Unless the context otherwise requires, all

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.12 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”), hereby unanimously consent to the following actions taken on Company on October 11, 2019. RESOLVED: To issue Iakovos Tsakalidis (“Tsakalidis”) a total of 80,282 shares

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.15 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”), hereby unanimously consent to the following actions taken on Company on October 11, 2019. RESOLVED: To issue Nikolai Ogorodnikov (“Ogorodnikov”) a total of 63,380 share

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.17 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”), hereby unanimously consents to the following actions taken by the Company on October 11, 2019. RESOLVED: To confirm the Consulting Agreement with PYP Enterprises dated

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

EX-10.3 11 tm2025150d1ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUC

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.5 STOCK ISSUANCE AGREEMENT This Stock Issuance Agreement (“Agreement”) is entered into as of the 29th day of November 2018 by and between Electromedical Technologies, Inc., a Delaware corporation (the “Company”), and E-Business International, Inc., an Oregon company, (“EBI”). WHEREAS, on or about 2005, EBI began rendering services to the Company; and WHEREAS, EBI has performed services

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.34 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (“Agreement”) is made and entered into this 12th day of June, 2020, by and between ElectroMedical Technologies, Inc., a Delaware corporation, with a business address of 16561 N 92nd Street Ste. 101, Scottsdale AZ 85260 (“Seller”), and ProActive Capital Partners, LP, a Delaware limited partnership, with a business address of 150 E

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.27 ADDENDUM TO SERIES 1 KISS AGREEMENT This Addendum to Series 1 Kiss Agreement ("Agreement") is entered into as of the 22nd day of March, 2019 by and between Electromedical Technologies, Inc., a Delaware corporation (the "Company"), and Blue Ridge Enterprises, LLC, a California Limited Liability Corporation ("BRE"). WHEREAS, on July 9, 2018 the Company and BRE entered into a Series 1 K

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.18 Consulting Agreement This consulting agreement (the “Agreement”) is made and entered on this day 1st day of July, 2019 (the “Effective Date”) by and between PYP Enterprises (hereinafter referred to as the “Consultant”) and Electromedical Technologies, Inc. (hereinafter referred to as the “Client”). 1. Services The Consultant will provide strategic business services to the Client, whi

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 3.1(ii)(e) BYLAWS OF ELECTROMEDICAL TECHNOLOGIES, INC. ARTICLE I CORPORATE OFFICES 1.1 Offices In addition to the corporation’s registered office set forth in the certificate of incorporation, the Board of Directors may at any time establish other offices at any place or places where the corporation is qualified to do business. ARTICLE II MEETINGS OF STOCKHOLDERS 2.1 Place Of Meetings Meet

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.32 Consulting Agreement This consulting agreement (the "Agreement") is made and entered on this day 11th day of February (the "Effective Date") by and between Robert L. Hymers III (hereinafter referred to as the "Consultant") and Electromedical Technologies, Inc. (hereinafter referred to as the "Client"). 1. Services The Consultant will provide strategic business and business services t

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.4 THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. ELECTROMEDICAL

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.31 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the "Company"), hereby unanimously consents to the following actions taken by the Company on October 31, 2018. RESOLVED: To accept the Accredited Subscription Agreement from Gene Taubm

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.20

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.22 Consulting AgreementThis consulting agreement (the "Agreement") is made and entered on this day 2/11/20 (the "Effective Date") by and between Robert L. Hymers III (hereinafter referred to as the "Consultant") and Electromedical Technologies, Inc. (hereinafter referred to as the "Client" or "ELCQ").1. ServicesThe Consultant will provide strategic business and business services to the

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.25 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the "Company"), hereby unanimously consent to the following actions taken on Company on October 25, 2019. RESOLVED: Due to a mathematical error on the part of the Company, to issue lak

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.28 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.29 NOTICE OF CONVERSION The undersigned hereby elects to convert their May 3, 2018 Convertible Promissory Note entered into with Electromedical Technologies, Inc., a Delaware corporation (the "Issuer"), in the principal amount of $25 ,000 of principal plus accrued interest of $2,947.75 totaling $27,947.75 into 39,363 shares of the Issuer's restricted Common Stock at the rate of$0. 71 pe

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.16 ELECTROMEDICAL TECHNOLOGIES, INC. AWARD AGREEMENT - 2017 EMPLOYEE AND CONSULTANT STOCK OWNERSHIP PLAN - OPTIONS Participant Name: Alexander Pedenko Participant ID: N/A Type of Option: Nonstatutory Stock Option Grant Date: 6/20/2019 Exercise Price: $0.71 Shares Granted: 100,000 Term and Vesting Date(s): Only if the participant is still a consultant or employee of Electromedical Techno

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.19 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is dated as of this 25th day of March, 2019 by and between Matthew Wolfson (the “Seller”) and Nicholas Rosin (the “Buyer’). WHEREAS, the Buyer is an employee of Electromedical Technologies, Inc., a Delaware company (the “Company’”); and WHEREAS, Previously, the Seller has orally agreed to sell 25,000 shares of his shares of the C

Stock Purchase Agreement dated June 4, 2020 with Vista Capital Investments, LLC.

Exhibit 10.35 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June 4, 2020, is entered into by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, (the “Company”), and VISTA CAPITAL INVESTMENTS, LLC (the “Buyer”). A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securitie

E-Business International, Inc. Stock Purchase Agreement Product Development, November 29, 2018.

Exhibit 10.6 DEVELOPMENT STOCK ISSUANCE AGREEMENT This Development Stock Issuance Agreement (“Agreement”) is entered into as of the 29th day of November, 2018 by and between Electromedical Technologies, Inc., a Delaware corporation (the “Company”), and E-Business International, Inc., a Oregon company, (“EBI”). NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein,

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.7 Consulting Agreement This consulting agreement (the “Agreement”) is made and entered on this day 1“ day of July, 2019 (the “Effective Date”) by and between Brenda Andrews (hereinafter referred to as the “Consultant”) and Electromedical Technologies, Inc. (hereinafter referred to as the “Client”). 1. Services The Consultant will provide strategic business services to the Client, which

Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on January 9, 2020.

Exhibit 3.1(i)(a) CERTIFICATE OF INCORPORATION OF ELECTROMEDICAL TECHNOLOGIES, INC. AS AMENDED JANUARY 9, 2020ARTICLE IThe name of the corporation is ElectroMedical Technologies, Inc. (the "Corporation").ARTICLE IIThe address of the Corporation's registered office in the State of Delaware is 1209 Orange Street - Corporation Trust Center, New Castle County, Wilmington, Delaware 19801. The name of i

- FORM S-1/A

As filed with the U.S. Securities and Exchange Commission July 20, 2020 Registration No. 333-234623 UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1/A-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 5047 (Primary Standard Industrial Cla

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.10 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is dated as of this 25th day of March, 2019 by and between Matthew Wolfson (the “Seller’) and Stephanie Kay Campbell (the “Buyer’). WHEREAS, the Buyer is an employee of Electromedical Technologies, Inc., a Delaware company (the “Company”); and WHEREAS, Previously, the Seller has orally agreed to sell 50,000 shares of his shares o

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.24

2017 Employee and Consultant Stock Ownership Plan

Exhibit 20.1

Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on August 23, 2017 converting from a limited liability company to a C corporation.

Exhibit 3.1(i)(d)

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.8

Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

Exhibit 10.33 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, ("the Company"), hereby unanimously consents to the following actions taken by the Company on June 28, 2019. RESOLVED: To amend the Company's Consulting Agreement dated February 11, 201

-

July 9, 2020 Eric Atallan Lynn Dicker United States Securities & Exchange Commission Division of Corporation Finance 100 F Street, NE Washington , D.

Stock Purchase Agreement dated June 15, 2020 with Pro Active Partners

Exhibit 10.34 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (“Agreement”) is made and entered into this 12th day of June, 2020, by and between ElectroMedical Technologies, Inc., a Delaware corporation, with a business address of 16561 N 92nd Street Ste. 101, Scottsdale AZ 85260 (“Seller”), and ProActive Capital Partners, LP, a Delaware limited partnership, with a business address of 150 E

Convertible Promissory Note, Ben and Carol Howden, May 2018

Exhibit 10.28 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

- FORM S-1/A

As filed with the U.S. Securities and Exchange Commission July 7, 2020 Registration No. 333-234623 UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM S-1/A-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ELECTROMEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 5047 (Primary Standard Industrial Clas

Agility Warrant Agreement, May 1, 2020

Exhibit 10.4 THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. ELECTROMEDICAL

Amended Consulting Agreement, Robert L. Hymers III, June 28, 2019

Exhibit 10.33 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, ("the Company"), hereby unanimously consents to the following actions taken by the Company on June 28, 2019. RESOLVED: To amend the Company's Consulting Agreement dated February 11, 201

Consent Action for Nikolai Ogorodnikov, October 25, 2019

Exhibit 10.26 CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the "Company"), hereby unanimously consent to the following actions taken on Company on October 25, 2019. RESOLVED: Due to a mathematical error on the part of the Company, to issue Nik

Option Agreement Kishkovskiy, March 11, 2019

Exhibit 10.13 ELECTROMEDICAL TECHNOLOGIES, INC. AWARD AGREEMENT - 2017 EMPLOYEE AND CONSULTANT STOCK OWNERSHIP PLAN - OPTIONS Participant Name: Kostiantyn Kishkovskiy Participant ID: N/A Type of Option: Nonstatutory Stock Option Grant Date: March 11, 2019 Exercise Price: $0.71 Shares Granted: 100,000 Term and Vesting Date(s): Only if the participant is still a consultant or employee of Electromedi

Certificate of Amendment [Increase of Authorized Common Stock to 50 million Shares]

Exhibit 3.1(i)(b) STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION The corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify: FIRST: That at a meeting of the Board of Directors of resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of said corporat